keyword
https://read.qxmd.com/read/38488952/towards-clinical-adherence-monitoring-of-oral-endocrine-breast-cancer-therapies-by-lc-hrms-method-development-validation-comparison-of-four-sample-matrices-and-proof-of-concept
#21
JOURNAL ARTICLE
Cathy M Jacobs, Julia C Radosa, Lea Wagmann, Julia S M Zimmermann, Askin C Kaya, Aylin Aygün, Tatjana Edel, Lisa Stotz, Mohamed Ismaeil, Erich-Franz Solomayer, Markus R Meyer
Oral endocrine therapies (OET) for breast cancer treatment need to be taken over a long period of time and are associated with considerable side effects. Therefore, adherence to OET is an important issue and of high clinical significance for breast cancer patients' caregivers. We hypothesized that a new bioanalytical strategy based on liquid chromatography and high-resolution mass spectrometry might be suitable for unbiased adherence monitoring (AM) of OET. Four different biomatrices (plasma, urine, finger prick blood by volumetric absorptive microsampling (VAMS), oral fluid (OF)) were evaluated regarding their suitability for AM of the OET abemaciclib, anastrozole, exemestane, letrozole, palbociclib, ribociclib, tamoxifen, and endoxifen...
March 15, 2024: Analytical and Bioanalytical Chemistry
https://read.qxmd.com/read/38471525/medicinal-use-of-different-cannabis-strains-results-from-a-large-prospective-survey-in-germany
#22
JOURNAL ARTICLE
Natalia Szejko, Eva Becher, Florian Heimann, Franjo Grotenhermen, Kirsten R Müller-Vahl
BACKGROUND: Up to now, it is unclear whether different medicinal cannabis (MC) strains are differently efficacious across different medical conditions. In this study, the effectiveness of different MC strains was compared depending on the disease to be treated. METHODS: This was an online survey conducted in Germany between June 2020 and August 2020. Patients were allowed to participate only if they received a cannabis -based treatment from pharmacies in the form of cannabis flowers prescribed by a physician...
March 12, 2024: Pharmacopsychiatry
https://read.qxmd.com/read/38470274/-dental-caries-the-most-common-noncommunicable-disease-and-its-impact-on-general-health-and-disease
#23
JOURNAL ARTICLE
Marie Nordström, Anders Hedenbjörk-Lager, Gunnel Hänsel Petersson, Dan Ericson
More than 2.8 billion individuals worldwide suffer from untreated caries. Over ninety-five percent of all 50-year-olds in Sweden have caries experience. Caries is the most common cause of dental restorations and tooth loss. Tooth loss is associated with cardiovascular diseases, dementia, and death. Periapical tooth infections caused by caries can spread and cause severe infection, however rarely with lethal outcome. Sugars are a common risk factor for caries and other noncommunicable diseases such as cardiovascular diseases, diabetes, and obesity...
March 12, 2024: Läkartidningen
https://read.qxmd.com/read/38470273/-adverse-drug-reactions-in-the-oral-cavity
#24
JOURNAL ARTICLE
Ylva Böttiger, Emma Ekenstråle
Adverse drug reactions commonly occur in the oral cavity, and although these reactions are seldom life threatening, they may severely affect quality of life, as well as the nutritional status of the patient. Hyposalivation is often caused by antidepressants, antihistamines, and diuretics, and the risk increases with polypharmacy. A dry mouth may in turn lead to oral candidosis, which may also be caused by treatment with antibiotics, immunosuppressants or corticosteroids. Other possible adverse drug reactions that may be seen in the oral cavity include gingival hyperplasia, ulcerations, allergic mucosal reactions, changes in sensibility or taste, as well as discoloration of saliva and/or the oral mucosa...
March 12, 2024: Läkartidningen
https://read.qxmd.com/read/38441659/mesenchymal-stem-stromal-cell-therapy-for-radiation-induced-xerostomia-in-previous-head-and-neck-cancer-patients-a-phase-2-randomised-placebo-controlled-trial
#25
JOURNAL ARTICLE
Kathrine Jakobsen, Amanda-Louise Fenger Carlander, Tobias Todsen, Jacob Melchiors, Natasja Paaske, Anne Kathrine Østergaard Madsen, Simone Kloch Bendtsen, Christine Mordhorst, Helene Stampe, Jens Kastrup, Annette Ekblond, Mandana Haack-Sørensen, Mohammad Farhadi, Christian Maare, Jeppe Friborg, Charlotte Duch Lynggaard, Anne Werner Hauge, Robin Christensen, Christian Grønhøj, Christian von Buchwald
PURPOSE: No effective treatment exists for radiation-induced xerostomia. The objective of this study was to compare the effect of adipose-derived mesenchymal stem/stromal cell (ASC) injection, relative to placebo, on salivary gland function in patients with radiation-induced xerostomia. PATIENT AND METHODS: In this single-centre, double-blind, placebo-controlled trial, patients with hyposalivation were randomised to receive ultrasound-guided injections of allogeneic ASCs or placebo into the submandibular glands...
March 5, 2024: Clinical Cancer Research
https://read.qxmd.com/read/38438317/a-review-of-animal-models-for-burning-mouth-syndrome-mechanistic-insights-and-knowledge-gaps
#26
REVIEW
Linda Sangalli, Alesia V Prakapenka, Akhilanand Chaurasia, Craig S Miller
OBJECTIVES: The underlying mechanisms of burning mouth syndrome (BMS) remain unclear leading to challenges and unsatisfactory management. Current treatments focus primarily on symptom relief, with few consistently achieving a 50% reduction in pain. This review aims to explore animal models of BMS to gain a better understanding of the underlying mechanisms and to discuss potential and existing knowledge gaps. METHODS: A comprehensive review of PubMed® , Google Scholar, and Scopus was performed to assess advances and significant gaps of existing rodent models that mimic BMS-related symptoms...
March 4, 2024: Oral Diseases
https://read.qxmd.com/read/38432870/hypoprothrombinemia-lupus-anticoagulant-syndrome-secondary-to-sjogren-s-syndrome-a-case-report
#27
JOURNAL ARTICLE
Wei Cai, Jingzhi Shen, Liangliang Ma
Hypoprothrombinemia-lupus anticoagulant syndrome (HLAS) is a rare disease in which patients present with varying degrees of bleeding and positive lupus anticoagulant with reduced prothrombin on laboratory tests. This article reports a case of HLAS in a middle-aged woman with recurrent gingival bleeding and epistaxis as the first presentation. After admission, tests revealed prolonged prothrombin time (PT), activated partial thromboplastin time (APTT), and reduced coagulation factor II activity, and positive lupus anticoagulant (LA)...
November 28, 2023: Zhong Nan da Xue Xue Bao. Yi Xue Ban, Journal of Central South University. Medical Sciences
https://read.qxmd.com/read/38430402/treatment-patterns-with-mirabegron-and-antimuscarinics-for-overactive-bladder-a-prospective-registry-study-in-taiwan-and-south-korea-faith
#28
JOURNAL ARTICLE
Seung-June Oh, Sung Tae Cho, Hann-Chorng Kuo, Eric Chieh-Lung Chou, Yu-Chao Hsu, Kyu-Sung Lee, Farid Hadi, Yi Song, Budiwan Sumarsono
INTRODUCTION: This study aimed to assess overactive bladder (OAB) treatment patterns and factors associated with effectiveness and persistence. METHODS: A prospective, longitudinal, observational registry study of adults starting OAB therapy with mirabegron or antimuscarinics was undertaken. Primary endpoints were time from treatment initiation to discontinuation/switching; proportion who discontinued/switched; and reasons for discontinuation/switching. Secondary endpoints included OAB Symptom Score (OABSS), OAB Questionnaire: Short Form, and OAB Bladder Assessment Tool scores; factors associated with effectiveness and persistence; and safety...
March 2, 2024: Advances in Therapy
https://read.qxmd.com/read/38422821/millets-as-a-dietary-supplement-for-managing-chemotherapy-induced-side-effects
#29
REVIEW
Swagata Dilip Tavhare
Millets, the nutria-cereals, are one of the oldest utilized grain. Millets are reported to possess nutraceuticals health benefits which include improvement in functioning of digestive system, reduction in cholesterol, prevention of heart disease, protection against diabetes, lowering risks of cancer etc. With the widespread commemoration of the International Year of Millets in 2023, the Indian government is moving towards the global recognition of millets in light of its medicinal value in correction of lifestyles diseases...
February 28, 2024: Journal of Ayurveda and Integrative Medicine
https://read.qxmd.com/read/38390068/a-rare-coexistence-of-sarcoidosis-with-overlap-syndrome-and-sarcoidosis-with-primary-biliary-cholangitis-and-sjogren-s-syndrome-two-distinct-case-reports
#30
Marwa Bougacha, Hana Blibech, Bouchra Bouchabou, Raja Jouini, Imen Helal, Houda Snene, Donia Belkhir, Nadia Mehiri, Rim Ennaifer, Achraf Chedly, Nozha Ben Salah, Bechir Louzir
Sarcoidosis and the overlap syndrome of autoimmune hepatitis and primary biliary cholangitis (PBC) share common clinical, biological, and histological features. The simultaneous occurrence of these diseases have been reported in few cases and suggests that a common pathway which may contribute to granuloma formation in both conditions. We report the cases of two female patients having an association of sarcoidosis and inflammatory liver diseases. The first case is of a 61-year-old woman had been monitored for an overlap syndrome of PBC and autoimmune hepatitis (AIH)...
February 29, 2024: Heliyon
https://read.qxmd.com/read/38368709/discovery-of-the-novel-and-potent-histamine-h1-receptor-antagonists-for-treatment-of-allergic-diseases
#31
JOURNAL ARTICLE
Zhaoxing Chu, Lifang Cen, Qinlong Xu, Gaofeng Lin, Jiajia Mo, Li Shao, Yan Zhao, Jiaming Li, Wenfeng Ye, Tao Fang, Weijie Ren, Qihua Zhu, Guangwei He, Yungen Xu
Desloratadine, a second-generation histamine H1 receptor antagonist, has established itself as a first-line drug for the treatment of allergic diseases. Despite its effectiveness, desloratadine exhibits an antagonistic effect on muscarinic M3 receptor, which can cause side effects such as dry mouth and urinary retention, ultimately limiting its clinical application. Herein, we describe the discovery of compound Ⅲ-4, a novel H1 receptor antagonist with significant H1 receptor antagonistic activity (IC50  = 24...
February 3, 2024: European Journal of Medicinal Chemistry
https://read.qxmd.com/read/38361712/a-systematic-review-of-the-efficacy-and-safety-of-mulberry-formulations-for-chemotherapy-and-or-radiotherapy-induced-oral-mucositis
#32
REVIEW
J Raghunand Sindhe, V Asha, Muthukrishnan Arvind, Shaik Shabana, A Sowbhagya Lakshmi, Khandekar Tanvi, Gimre Ananta
Oral mucositis (OM) is one of the common side effects of radiotherapy and chemotherapy. It is an extremely painful condition characterized by erythema, edema, and ulceration of the oral mucosa. Many plant-based and chemical formulations are used to prevent OM. The aim of the study is to evaluate the efficacy and safety of different black mulberry formulations in chemotherapy and/or radiotherapy-induced OM. A systematic search was performed using PubMed, Excerpta Medica database (Embase), the Cochrane Library, and Web of Science databases for articles published until March 2023...
January 2024: Curēus
https://read.qxmd.com/read/38344178/pharmacokinetics-pharmacodynamics-and-safety-of-15%C3%A2-mg-tolvaptan-administered-orally-for-7-consecutive-days-to-chinese-patients-with-child-pugh-b-cirrhosis
#33
JOURNAL ARTICLE
Hongzhong Liu, Yongfeng Wang, Tao Liu, Yingxuan Chen, Xin Zheng, Ming Liu, Qian Zhao, Minde Zeng, Ji Jiang, Yimin Mao, Pei Hu
Background: Tolvaptan, a selective vasopressin V2 -receptor antagonist, can elicit a diuretic effect without significant electrolyte loss. The aims were to evaluate multiple-dose pharmacokinetics, pharmacodynamics and safety of daily administration of 15 mg tolvaptan in Chinese adult patients with confirmed Child-Pugh Class B cirrhosis accompanied by ascites. Methods: This was an open-label, single-center, single- and multiple-dose study. All patients received a daily 15 mg dose of tolvaptan for 7 consecutive days...
2024: Frontiers in Pharmacology
https://read.qxmd.com/read/38326771/longevity-of-dental-restorations-in-sjogren-s-disease-patients-using-electronic-dental-and-health-record-data
#34
JOURNAL ARTICLE
Grace Gomez Felix Gomez, Mei Wang, Zasim A Siddiqui, Theresa Gonzalez, Oriana R Capin, Lisa Willis, LaKeisha Boyd, George J Eckert, Domenick T Zero, Thankam Paul Thyvalikakath
BACKGROUND: Decreased salivary secretion is not only a risk factor for carious lesions in Sjögren's disease (SD) but also an indicator of deterioration of teeth with every restorative replacement. This study determined the longevity of direct dental restorations placed in patients with SD using matched electronic dental record (EDR) and electronic health record (EHR) data. METHODS: We conducted a retrospective cohort study using EDR and EHR data of Indiana University School of Dentistry patients who have a SD diagnosis in their EHR...
February 7, 2024: BMC Oral Health
https://read.qxmd.com/read/38324402/superior-orbital-fissure-syndrome-in-the-setting-of-relapsing-polychondritis-with-concurrent-sjogren-s-syndrome-a-case-report
#35
JOURNAL ARTICLE
Vishnusai Karri, Abdullah Abou-Samra, Brian King, Adam Carlson, Arthi Venkat
PURPOSE: Ophthalmic manifestations of varying severity are often associated with systemic autoimmune conditions. Superior orbital fissure syndrome (SOFS) is a rare cranial neuropathy affecting nerves passing through the superior orbital fissure that causes a distinctive pattern of extraocular and pupillary findings. We report the coexistence of SOFS, relapsing polychondritis (RP) and Sjögren's syndrome (SS) in a 52-year-old female who presented with a past medical history of hypothyroidism, Raynaud's syndrome, and intermittent dry mouth and a 1-week history of worsening chemosis, proptosis, diplopia, and painful ophthalmoplegia...
February 7, 2024: Ocular Immunology and Inflammation
https://read.qxmd.com/read/38324078/intensity-modulated-radiotherapy-alone-compared-with-intensity-modulated-radiotherapy-plus-concurrent-chemotherapy-in-intermediate-risk-nasopharyngeal-carcinoma-a%C3%A2-prospective-multicenter-phase%C3%A2-ii-trial
#36
JOURNAL ARTICLE
Shufang Liao, Bin Zhang, Yixin Su, Yufei Pan, Jian Zhang, Zhenkai Ye, Rongjun Zhang, Xiangyun Kong, Guanjie Qin, Yunyan Mo, Xiaolan Ruan, Jian Liu, Chunqiao Gan, Jinxuan Dai, Ruyun Zhang, Guanhong Luo, Xiaofei Liao, Wei Jiang
BACKGROUND: This study aimed to investigate the clinical benefit of adding concurrent chemotherapy to intensity-modulated radiotherapy (IMRT) for nasopharyngeal carcinoma (NPC) patients with an intermediate risk (stage II and T3N0M0). METHODS: A multicenter phase II randomized trial was conducted in intermediate-risk NPC patients. Enrolled patients were previously untreated and aged ranged from 18 to 70 years without severe coexisting diseases...
February 7, 2024: Strahlentherapie und Onkologie: Organ der Deutschen Röntgengesellschaft ... [et Al]
https://read.qxmd.com/read/38313227/current-developments-and-opportunities-of-pluripotent-stem-cells-based-therapies-for-salivary-gland-hypofunction
#37
REVIEW
Wenpeng Song, Huan Liu, Yingying Su, Qian Zhao, Xiaoyan Wang, Pengfei Cheng, Hao Wang
Salivary gland hypofunction (SGH) caused by systemic disease, drugs, aging, and radiotherapy for head and neck cancer can cause dry mouth, which increases the risk of disorders such as periodontitis, taste disorders, pain and burning sensations in the mouth, dental caries, and dramatically reduces the quality of life of patients. To date, the treatment of SGH is still aimed at relieving patients' clinical symptoms and improving their quality of life, and is not able to repair and regenerate the damaged salivary glands...
2024: Frontiers in Cell and Developmental Biology
https://read.qxmd.com/read/38312044/long-term-health-related-quality-of-life-in-head-and-neck-cancer-survivors-a-large-multinational-study
#38
JOURNAL ARTICLE
Katherine J Taylor, Cecilie D Amdal, Kristin Bjordal, Guro L Astrup, Bente B Herlofson, Fréderic Duprez, Ricardo R Gama, Alexandre Jacinto, Eva Hammerlid, Melissa Scricciolo, Femke Jansen, Irma M Verdonck-de Leeuw, Giuseppe Fanetti, Orlando Guntinas-Lichius, Johanna Inhestern, Tatiana Dragan, Alexander Fabian, Andreas Boehm, Ulrike Wöhner, Naomi Kiyota, Maximilian Krüger, Pierluigi Bonomo, Monica Pinto, Sandra Nuyts, Joaquim Castro Silva, Carmen Stromberger, Pol Specenier, Francesco Tramacere, Ayman Bushnak, Pietro Perotti, Michaela Plath, Alberto Paderno, Noa Stempler, Maria Kouri, Vincent Grégoire, Susanne Singer
Head and neck cancer (HNC) patients suffer from a range of health-related quality of life (HRQoL) issues, but little is known about their long-term HRQoL. This study explored associations between treatment group and HRQoL at least 5 years' post-diagnosis in HNC survivors. In an international cross-sectional study, HNC survivors completed the European Organization for Research and Treatment of Cancer (EORTC) quality of life core questionnaire (EORTC-QLQ-C30) and its HNC module (EORTC-QLQ-H&N35). Meaningful HRQoL differences were examined between five treatment groups: (a) surgery, (b) radiotherapy, (c) chemo-radiotherapy, (d) radiotherapy ± chemotherapy and neck dissection and (e) any other surgery (meaning any tumour surgery that is not a neck dissection) and radiotherapy ± chemotherapy...
February 5, 2024: International Journal of Cancer. Journal International du Cancer
https://read.qxmd.com/read/38304225/effects-of-phentermine-topiramate-extended-release-phentermine-and-placebo-on-ambulatory-blood-pressure-monitoring-in-adults-with-overweight-or-obesity-a-randomized-multicenter-double-blind-study
#39
JOURNAL ARTICLE
Harold E Bays, Daniel S Hsia, Lan T Nguyen, Craig A Peterson, Santosh T Varghese
BACKGROUND: A fixed-dose combination of phentermine and extended-release topiramate (PHEN/TPM - approved for weight management) has demonstrated in-clinic reduction of blood pressure (BP). Ambulatory BP monitoring (ABPM) may be a better predictor of cardiovascular disease risk than in-clinic BP. METHODS: This randomized, multicenter, double-blind study enrolled 565 adults with overweight/obesity. Inclusion criteria included participants willing to wear ABPM device for 24 h...
March 2024: Obes Pillars
https://read.qxmd.com/read/38297035/oral-health-related-quality-of-life-in-head-and-neck-cancer-survivors-within-the-first-year-following-treatment-a-cross-sectional-study-in-karachi-pakistan
#40
JOURNAL ARTICLE
Sana Qamar, Shafquat Rozi, Sobia Sawani, Muhammad Sohail Awan, Shabbir Akhtar, Moghira Iqbaluddin Siddiqui, Syed Akbar Abbas, Shazia Taimoor, Farhan Raza Khan
After completing treatment for head and neck cancer (HNC), patients often face oral complications like oral pain, limited mouth opening and dry mouth which significantly reduce their oral health related quality of life (OHRQoL). These issues impact their overall well-being, social activities and long-term survival. The primary objective of this study was to evaluate OHRQoL and its association with sociodemographic characteristics, oral hygiene practices and oral clinical parameters such as oral hygiene status and oral mucositis grade in patients who have completed treatment for head and neck cancer...
January 31, 2024: Scientific Reports
keyword
keyword
97779
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.